As governments all around the world continue to implement measures to curb the outbreak of COVID-19, businesses in many industries will suffer from reduced customers, reduced revenue and disruptions to supply chains and business practices. This may, in turn, have a significant adverse impact on their ability to operate and on the obligations and requirements that they face.
In this note, we consider some specific areas of business operations, namely contractual obligations, regulatory and statutory disclosure requirements on listed issuers and the holding of board meetings and general meetings and also some deal-related issues.
Click here to read the full article.